<code id='35915F6936'></code><style id='35915F6936'></style>
    • <acronym id='35915F6936'></acronym>
      <center id='35915F6936'><center id='35915F6936'><tfoot id='35915F6936'></tfoot></center><abbr id='35915F6936'><dir id='35915F6936'><tfoot id='35915F6936'></tfoot><noframes id='35915F6936'>

    • <optgroup id='35915F6936'><strike id='35915F6936'><sup id='35915F6936'></sup></strike><code id='35915F6936'></code></optgroup>
        1. <b id='35915F6936'><label id='35915F6936'><select id='35915F6936'><dt id='35915F6936'><span id='35915F6936'></span></dt></select></label></b><u id='35915F6936'></u>
          <i id='35915F6936'><strike id='35915F6936'><tt id='35915F6936'><pre id='35915F6936'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:66
          Martin Shkreli Securities Fraud Trial
          Kevin Hagen/Getty Images

          Is this the end of the line for the “pharma bro” with the perpetual smirk?

          Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.

          advertisement

          “This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          'Null' research findings aren't empty of meaning. Let's publish them
          'Null' research findings aren't empty of meaning. Let's publish them

          APStockEverymedicalresearcherdreamsofdoingstudiesorconductingclinicaltrialsthatgenerateresultssocomp

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

          AllenG.Breed/APNewbiotechnewsletterlaunchingthisThursday.Don’tmissout.Heythere.Today,wediscusstheimp